Investor Relations

Home / Investors

Overview.

THC Therapeutics (OTC: THCT) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. THC Therapeutics is traded on the OTC under the ticker symbol THCT.

THC Therapeutics is a forward-thinking publicly traded company in the cannabis industry focusing on health and healing. The company is developing their patent-pending product the dHydronator®, a sanitizing herb dryer. The main function of the dHydronator is to greatly accelerate drying time and destroy surface bacteria and contaminants. The dHydronator is proven to reduce the drying time from 10-14 days to less than 14 hours. THC Therapeutics plans to get involved in cannabis testing lab facilities and personal wellness centers. The Company is seeking partnerships, mergers and acquisitions in the cannabis, health and healing industries.

Latest News

THCT
OTC

VOLUME
CHANGE

Investor Updates.

Keep up to date on THC Therapeutics News. Simply fill out your
email below and you will be added to our email newsletter.


By clicking submit, you are agreeing to our Terms & Conditions